1. Pink Sheet

Netherlands Follows Belgium & Luxembourg In Piloting Electronic Medicine Pack Leaflets

 
• By Francesca Bruce

The aim of the pilot project is to demonstrate that an electronic package leaflet has no negative effects on the proper use of medicinal products in a hospital setting, says the industry body VIG. 

DUTCH FLAG
The Netherlands Wants To Pilot Electronic Patient Information Leaflets For Hospital Drugs • Source: Shutterstock

VIG, the Dutch innovative medicines association, plans to run a pilot on replacing paper pack information leaflets (PILs) for hospital medicines with electronic versions. However, permission for a derogation from an EU Directive must first be granted.

In late June, the then minister for medical care, Pia Dijkstra, wrote to the European Commission for permission to run the pilot, which would require approval to derogate from Article 58 of the human-use medicines Directive 2001/83/EC

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

House Budget Bill Includes Delayed Orphan Fix, Also Risks Downstream Cell and Gene Coverage

 
• By Sarah Karlin-Smith

The first two classes of negotiated drugs under the Inflation Reduction Act would not benefit from a rare disease adjustment House Republicans included in their reconciliation package.

Trump’s Rx Pricing Order: The Best-Case And Worst-Case Scenarios

 
• By Derrick Gingery

US trade and tariff leverage might successfully push European and other countries to pay more for medicines, but if not, President Trump’s executive order includes potential US drug withdrawal and other options to entice industry to lower US prices.

International Group Aims To Shape The Inevitable Future Of AI In Pharmacovigilance

 
• By Urtė Fultinavičiūtė

Pharmacovigilance is a perfect rule-based and manual work-intensive playground for experimenting with AI. While some off-patent drug firms are already exploring new automation tools, regulation is lagging behind, leaving a gap for uncertainty.